机译:弥漫性大B细胞淋巴瘤的遗传异质性
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710,Duke Cancer Institute and Department of Medicine, Duke University, Durham, NC 27710;
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710;
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710;
Department of Statistical Science, Duke University, Durham, NC 27710;
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
The University of Hong Kong, Queen Mary Hospital, Hong Kong, China;
The University of Hong Kong, Queen Mary Hospital, Hong Kong, China;
The University of Hong Kong, Queen Mary Hospital, Hong Kong, China;
Duke University Medical Center, Durham NC 27710;
Duke University Medical Center, Durham NC 27710;
Duke University Medical Center, Durham NC 27710;
Emory University, Atlanta GA 30322;
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
Emory University, Atlanta GA 30322;
Imperial College, London, United Kingdom;
University of Massachusetts, Worcester, MA 01655;
Northwestern University, Chicago IL 60208;
Indiana University, Indianapolis IN 46202;
Baylor University Medical Center, Dallas TX 75246;
Cleveland Clinic, Cleveland, OH 44195;
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710;
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710;
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710;
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710;
Division of Hematology and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;
Division of Hematology and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;
Division of Hematology and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;
Duke University Medical Center, Durham NC 27710;
Genetics and Development Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892;
Genetics and Development Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892;
Northwestern University, Chicago IL 60208;
Hudson Alpha Institute for Biotechnology, Huntsville, AL 35806;
Department of Statistical Science, Duke University, Durham, NC 27710;
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710,Duke Cancer Institute and Department of Medicine, Duke University, Durham, NC 27710,Duke University Medical Center, Durham NC 27710;
next-generation sequencing; cancer genetics; cancer heterogeneity;
机译:滤泡性淋巴瘤的GWAS显示6p21.32的等位基因异质性,并建议与弥漫性大B细胞淋巴瘤共享遗传易感性。
机译:T细胞/组织细胞丰富的大型B细胞淋巴瘤显示出与弥漫性大型B细胞淋巴瘤相似的异质性:30例临床病理,免疫组织化学和分子研究。
机译:差异FDG-PET反应在弥漫性大B细胞淋巴瘤中突出的遗传异质性
机译:使用遗传程序分类器对弥漫性大B细胞淋巴瘤进行分类
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:弥散性大B细胞淋巴瘤中FDG-PET反应差异突出了遗传异质性
机译:滤泡性淋巴瘤的GWAS显示6p21.32的等位基因异质性 并建议与弥漫性大B细胞共享遗传易感性 淋巴瘤